Established in December 2021 and strategically located within the Modern Pharmaceutical Harbor of Heze, Shandong Province, Ruzhi Biomed stands as a premier CRO. Founded by renowned experts in the field, our company specializes in providing cutting-edge services for drug R&D.

Core Services

Moreover, leveraging our strategic affiliation with Chiheal Pharma Factory, we offer comprehensive CDMO services. This synergistic approach creates a robust CXO+MAH collaboration platform. Serving both as a research and development entity and as an MAH holding company, Ruzhi Biomed has actively engaged in partnerships with prominent enterprises such as Huabei Pharmaceutical, Sanjiu Pharmaceutical, Southwest Pharmaceutical, among others. Our workforce, with 30% holding master's degrees and 95% possessing a bachelor's degree or higher, reflects our commitment to excellence. With a well-established R&D Quality Management System and MAH Quality Assurance System, we are positioned for continuous growth and success on both the CXO and MAH platforms.